Optimizing detection of Alzheimer ’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO

Disease-modifying drug use necessitates better Alzheimer disease (AD) detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk group; similarly, mild behavioral impairment (M...

Source: Molecular Neurodegeneration - July 29, 2023 Category: Neurology Authors: Zahinoor Ismail, Rebeca Leon, Byron Creese, Clive Ballard, Philippe Robert and Eric E. Smith Tags: Research article Source Type: research